45 Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(−) chronic hepatitis B patients (study ETV-027)
D. Shouval, U.S. Akarca, G. Hatzis, G. Kitis, C.L. Lai, H. Cheinquer, T.T. Chang, R. Zink, J. Zhu, H. Brett-SmithVolume:
44
Year:
2006
Language:
english
DOI:
10.1016/s0168-8278(06)80046-2
File:
PDF, 239 KB
english, 2006